IMMU

Immunomedics, Inc. Press Releases

$3.14
*  
0.01
  negative  
0.32%
Get IMMU Alerts
*Delayed - data as of May 22, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program Developments
05/08/2013 4:00PM - GlobeNewswire

Immunomedics Announces Three New Patent Awards
05/07/2013 8:30AM - GlobeNewswire

Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial Results
04/25/2013 8:30AM - GlobeNewswire

Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors
04/10/2013 8:30AM - GlobeNewswire

Immunomedics Reports First Results of Labetuzumab-SN-38 in Colorectal Cancer
04/09/2013 8:30AM - GlobeNewswire

Immunomedics Creates Novel Antibody-Cytokine Conjugates for Cancer Therapy
04/08/2013 4:30PM - GlobeNewswire

Immunomedics Announces Clivatuzumab-Based Blood Test Can Differentiate Between Pancreatic Cancer and Chronic Pancreatitis
04/08/2013 1:00PM - GlobeNewswire

Immunomedics Settles Finra Arbitration Proceedings Relating to Its Prior Investment in Certain Securities
04/01/2013 5:01PM - GlobeNewswire

Immunomedics Announces Presentations at the 2013 Annual Meeting of the American Association for Cancer Research
04/01/2013 8:30AM - GlobeNewswire

Immunomedics Announces Closing of Public Offering and Full Exercise of Overallotment Option by Underwriters
02/27/2013 4:01PM - GlobeNewswire

Immunomedics to Present at Cowen and Company 33rd Annual Health Care Conference
02/25/2013 8:30AM - GlobeNewswire

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
02/25/2013 8:20AM - Market Wire